These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1491301)

  • 1. Resistance of Trypanosoma cruzi to blood clearance induced by acute-phase immune mouse serum.
    Alvarez JM; Marinho CR; Oshima A; Guimaraes L; Menezes H
    J Parasitol; 1992 Dec; 78(6):1074-7. PubMed ID: 1491301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of membrane-bound IgM in Trypanosoma cruzi evasion from immune clearance.
    Garcia IE; Lima MR; Marinho CR; Kipnis TL; Furtado GC; Alvarez JM
    J Parasitol; 1997 Apr; 83(2):230-3. PubMed ID: 9105302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive immunization of mice against Trypanosoma cruzi using convalescent mouse serum.
    McHardy N
    Tropenmed Parasitol; 1977 Jun; 28(2):195-201. PubMed ID: 407684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agglutination of Trypanosoma cruzi in infected cells treated with serum from chronically infected mice.
    Wendelken JL; Rowland EC
    J Parasitol; 2009 Apr; 95(2):337-44. PubMed ID: 18922039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-independent, natural resistance of birds to Trypanosoma cruzi infection.
    Kierszenbaum F; Gottlieb CA; Budzko DB
    J Parasitol; 1981 Oct; 67(5):656-60. PubMed ID: 6795329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES; Shikanai-Yasuda MA; Stolf AM
    J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi antigen-specific antibody response in immunized mice during acute and chronic infection.
    Mikhail KS; Rowland EC
    J Parasitol; 1990 Oct; 76(5):690-7. PubMed ID: 2120413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.
    Tarleton RL
    J Immunol; 1990 Jan; 144(2):717-24. PubMed ID: 2104903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vertical transmission of Trypanosoma cruzi in Wistar rats during the acute phase of infection].
    Moreno EA; Rivera IM; Moreno SC; Alarcón ME; Lugo-Yarbuh A
    Invest Clin; 2003 Sep; 44(3):241-54. PubMed ID: 14552062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytophilic antibody in experimental Chagas' disease.
    Kuhn RE; Cassida GW
    J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous lytic activity against allogeneic tumor cells and depression of specific cytotoxic responses in mice infected with Trypanosoma cruzi.
    Hatcher FM; Kuhn RE
    J Immunol; 1981 Jun; 126(6):2436-42. PubMed ID: 6785354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity.
    Taibi A; Plumas-Marty B; Guevara-Espinoza A; Schöneck R; Pessoa H; Loyens M; Piras R; Aguirre T; Gras-Masse H; Bossus M
    J Immunol; 1993 Sep; 151(5):2676-89. PubMed ID: 7689612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
    Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-antibody-mediated control of parasitemia in acute experimental Chagas' disease.
    Trischmann TM
    J Immunol; 1983 Apr; 130(4):1953-7. PubMed ID: 6403614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.